Inside Reproductive Health Podcast Fertility Bridge

Growing fertility networks need more staff at almost every level of the organization. But they can’t get enough of them.

Today's guest, Beth Zoneraich, CEO of Pinnacle Fertility, presents her approach to revolutionizing the patient experience and enhancing efficiency in fertility practices.

Tune in as Beth explores:


How she’s refining the patient journey for optimal efficiency. (And why it involves the Ritz-Carlton)


Market and workforce factors driving the need for more streamlined processes.


Pinnacle's automation of EMR steps and improvements in patient intake.


Strategies for segmenting and training specialized support staff.


Navigating the separation between business and medicine in fertility.


The impact of private equity on fertility practices and standards of care.

How did Maven turn into a unicorn, a new company with a $1Billion valuation? How did they raise $300M?

Find out with today’s guest, Kate Ryder, Founder & CEO of Maven Clinic, as she reveals the strategies behind Maven’s extraordinary success and how she built a three comma company.

Tune in as Kate takes us behind the scenes of Maven, covering:


The secrets to making TTC coaching work within their business model (Even though its failed in so many others)


The formation and impact of Maven Managed Benefit (Their carve-out admin program)


Her vision for the future of managed care in fertility (And how traditional insurance may adapt)


Lessons learned from her time in venture capital that shaped her entrepreneurial journey


Her approach to hiring experts and building top-tier leadership

Are you considering the broader implications of third-party IVF in your practice?

Today’s guest, Melissa Lindsey, Founder of the non-profit Donor Conceived Community and a member of the donor-conceived community herself, delves into the ethical and real-life consequences of third-party IVF. She offers a much-needed perspective on how clinics and egg banks can better serve donor-conceived persons

Tune in as Melissa discusses:


What clinics and egg banks are doing wrong (and what some are doing right)
Why Everie isn’t scared of the DCC (Instead taking a proactive interest)
Last year’s legislation in Colorado
What’s fair for donor-conceived persons to expect vs. what someone can require of their own biological parents
The real-life consequences for a donor-conceived person (False medical history, denied genetic testing, etc.)

Since 2019, Inside Reproductive Health has conducted over 220 interviews, featuring prominent physicians and executives from numerous fertility companies.



Among them, nine CEOs continue to lead their respective Fertility Clinic Networks or chair their network’s board.



Together, their networks have overseen an estimated 1.6 million IVF cycles and other reproductive treatments that have resulted in over 2 million pregnancies,



This is an episode you don’t want to miss as we showcase:


Gina Bartasi and the only three things she believes matter in healthcare
Dave Burford sharing his battle-tested sales advice
TJ Farnsworth’s entrepreneurial journey and his perspective on the necessities of field wide collaboration.
Dr. Kshitiz Murdia’s reasoning on why doctors make good CEOs
Marc Segal’s perspective on private equity and its place in Fertility’s future
Francisco Lobbosco’s first 100 days as CEO and the power of listening
David Stern’s steps to finding the right financial partner (Hint: It’s like a marriage)
Lisa Van Dolah’s philosophy of transitioning nurses into executive leadership roles
Andrew Meikle discussing the power of perspective (Both patient & entrepreneur)

When will embryologists be robots?

Dr. Jacques Cohen, Chief Scientific Officer of Conceivable Life Sciences, walks us through the research and development currently underway for the automation of the IVF lab.

Tune in to hear Dr. Cohen discuss:


The next potential game changing innovations in IVF


His opinion on time-lapse incubation and its future in the lab


What the FDA doesn’t like about AI solutions


The $1B project to automating the IVF lab

What do embryologists do when they own stake in the company?

If you’re Professor Alison Campbell, Chief Scientific Officer and equity owner at Care Fertility, you’d build massive datasets to train a machine learning system to predict live births.

With Alison we dive into:


Their proprietary Caremaps-AI system (Saving 10 weeks of Embryologist time per year)


Why CARE is building a machine learning system rather than using AI software already on the market


How she pitted 10 of her best embryologists against an AI software she was skeptical of (And who won!)
The one AI solution she likes for egg freezing (Why CARE Fertility uses that rather than building their own)